info@mail.ucallm.com
From Spatial Organization to Cell Fate Determination — Empowering Precision Investigation of Hematopoietic Stem Cell Polarity, Asymmetric Division, and Lineage Commitment with Validated Antibody Solutions
Cell polarity is a fundamental biological mechanism that enables cells to establish spatial organization, directional migration, asymmetric protein inheritance, and differential daughter-cell fate determination.
In hematopoietic stem and progenitor cells (HSPCs), polarity-controlled asymmetric division provides a critical mechanism for balancing:
· Stem cell self-renewal and differentiation
· Maintenance of hematopoietic hierarchy
· Microenvironment sensing and niche interaction
· Cell migration and homing behavior
· Age-associated stem cell functional decline
HSPC polarity and asymmetric division are regulated by interconnected molecular networks involving:
· Cell polarity establishment and spatial signaling
· Asymmetric segregation of membrane proteins and endosomal compartments
· Uropod formation and directional migration
· Cytoskeletal remodeling and cortical tension regulation
· Notch-mediated daughter-cell fate specification
We provide comprehensive antibody solutions for dissecting HSPC polarity mechanisms — from CD63/CD71-associated asymmetric vesicle inheritance and uropod polarity markers to Cdc42-driven polarity signaling and Notch-dependent fate regulation.
Validated antibody solutions enable researchers to:
✓ Identify polarized membrane and vesicular structures during asymmetric division
✓ Monitor HSPC polarity establishment and migration behavior
✓ Analyze asymmetric segregation of fate-determining molecules
✓ Investigate cytoskeletal control of stem cell division orientation
✓ Study Notch-mediated lineage commitment mechanisms
✓ Perform high-resolution imaging of polarity-associated molecular organization
Hematopoietic Stem Cell Polarity & Asymmetric Division Biomarker Antibody Portfolio
—Comprehensive Solutions for Spatial Organization, Fate Determination, Migration Polarity, and Stem Cell Maintenance
HSPC asymmetric division is controlled by interconnected molecular networks regulating:
Research Module | Representative Biomarkers | Research Applications |
Asymmetric Vesicle Segregation & Organelle Inheritance | CD63, CD53, TFRC,LAMP1, RAB5A, RAB7A, RAB11A | Visualization of polarized endosomal compartments and asymmetric inheritance during mitosis |
Uropod Formation & Migration Polarity | PROM1, ICAM1, ICAM3, SPN, CD44, SELL | Analysis of leukocyte polarity, directional migration, and HSPC homing behavior |
Cell Polarity Establishment Network | CDC42, PARD3, PARD6A, PRKCZ, PRKCI, NUMB, NUMBL | Investigation of polarity axis formation and asymmetric fate regulation |
Cytoskeletal Remodeling & Division Orientation | MYH9, MYH10, ROCK1, ROCK2, ACTB, ACTG1, p-MYL9 Ser19,GPSM2, NUMA1, INSC, DYNC1H1 | Analysis of cortical tension, spindle orientation, and mechanical regulation |
Stem Cell Fate Specification Pathway | NOTCH1（Cleaved NOTCH1 Val1744）, JAG1, DLL1, DLL4, NUMB, HES1, HEY1 | Investigation of daughter-cell fate divergence and lineage commitment |
HSPC Identity & Experimental Controls | D34, PTPRC, PROM1 | Identification of hematopoietic populations and polarity assay controls |
Cell Polarity & Asymmetric Division Regulatory Network
—Master Regulators Controlling Spatial Organization, Unequal Molecular Inheritance, and Hematopoietic Cell Fate Decisions
HSPC asymmetric division is governed by a hierarchical regulatory network integrating polarity signaling, membrane organization, cytoskeletal mechanics, and fate-determining pathways.
Target | Biological Role | Antibody Research Application |
CDC42 | Master polarity regulator controlling cell orientation, migration polarity, and asymmetric stem cell division | Analysis of polarity establishment, HSPC aging mechanisms, and asymmetric division regulation |
PAR3 / PARD3 | Scaffold protein defining the apical-basal polarity axis and organizing polarity complexes | Visualization of polarity domain formation during cell division |
PAR6 / PARD6 | Adapter protein connecting CDC42 signaling with aPKC polarity complex activation | Investigation of polarity signaling assembly |
aPKC (PKCζ/PKCι) | Polarity kinase controlling asymmetric protein localization and fate determination | Detection of polarity pathway activation and spatial distribution |
NUMB | Endosomal adaptor regulating Notch signaling and asymmetric cell fate decisions | Study of asymmetric inheritance mechanisms and stem cell differentiation |
NOTCH1 | Stem cell niche receptor controlling lineage commitment through cell–cell signaling | Analysis of hematopoietic fate specification pathways |
JAG1 / DLL1/DLL4 | Notch ligands regulating HSC maintenance and differentiation cues | Investigation of niche-derived signaling regulation |
CD63 | Tetraspanin-associated endosomal marker enriched in asymmetrically inherited vesicles | IF imaging of asymmetric vesicle segregation during HSPC division |
CD71/TFRC | Transferrin receptor localized to polarized endosomal compartments | Analysis of asymmetric endosomal inheritance and metabolic regulation |
CD53 | Tetraspanin family member associated with polarized vesicle distribution | Detection of asymmetric membrane organization |
Non-muscle Myosin II | Actomyosin regulator controlling division mechanics and fate choice through matrix sensing | Investigation of mechanical regulation of asymmetric division |
ROCK1/2 | Rho downstream kinases regulating contractility and cytoskeletal organization | Analysis of polarity-dependent cytoskeletal remodeling |
Featured HSPC Cell Polarity & Asymmetric Division Research Panels
—Integrated Antibody Panels for Stem Cell Polarity, Division Orientation, Fate Regulation, and Migration Behavior
Hematopoietic stem and progenitor cell (HSPC) fate is precisely regulated by cell polarity establishment, asymmetric distribution of signaling molecules, organelle inheritance, and niche-dependent signaling pathways.
n Direct Asymmetric Division Marker Panel—Monitoring Unequal Molecular Distribution During Hematopoietic Stem Cell Division
Key Markers
CD63 | CD53 | CD71/TFRC | LAMP1 |
n Asymmetric Vesicle Inheritance Panel—Visualizing polarized organelle distribution during stem cell division
Key Markers
CD63 | CD53 | CD71/TFRC | LAMP1 | RAB5A |
n HSPC Polarity Establishment Panel—Decoding molecular mechanisms controlling spatial organization
Key Markers
CDC42 | PARD3 | PARD6A | PRKCZ | NUMB |
n HSPC Migration & Uropod Polarity Panel—Characterizing directional migration and niche homing behavior
Key Markers
PROM1 | ICAM-1/CD54 | ICAM-3/CD50 | SPN | CD44 | SELL |
n Notch-Mediated Fate Specification Panel—Understanding daughter-cell fate decisions after asymmetric division
Key Markers
Cleaved NOTCH1 | JAG1 | DLL1/DLL4 | NUMB | HES1 |
Why Researchers Choose Our HSPC Cell Polarity & Asymmetric Division Antibody Solutions
Validated Polarity Markers. Integrated Stem Cell Panels. Mechanistic Insights into Hematopoietic Fate Regulation
Our antibody portfolio enables comprehensive analysis of HSPC polarity biology — from membrane asymmetry and organelle inheritance to fate determination, migration, and regenerative capacity.
Research Challenge | Biological Question | Validated Antibody Solution |
How can I detect asymmetric division events in HSPCs? | Which molecular components are unequally inherited during mitosis? | CD63, CD53, CD71, CD62L polarity markers for asymmetric segregation analysis |
How can I analyze HSPC polarity and migration behavior? | How do hematopoietic cells establish directional movement? | CD133, ICAM-1, ICAM-3, CD43, CD44 uropod and migration markers |
How can I investigate stem cell fate decisions? | Which pathways regulate daughter-cell differentiation outcomes? | NUMB, NOTCH1, JAG1, DLL1/DLL4 signaling pathway markers |
How can I validate HSPC identity during polarity studies? | Are polarized cells maintaining primitive stem/progenitor characteristics? | CD34, CD45, CD133 multiparameter phenotyping panel |
How can I perform spatial analysis of polarized HSPCs? | Where are polarity-associated proteins localized within cells and tissues? | Multiplex IF/IHC-compatible validated antibody solutions |
Key reference
1. Andersson R., Mejia-Ramirez E., Florian M.C. (2025). Haematopoietic ageing in health and lifespan. Nature Cell Biology. 27:1398–1410.
2. Ugale A., et al. (2024). Signaling proteins in HSC fate determination are unequally segregated during asymmetric cell division. Journal of Cell Biology. 223:e202310137.
3. Arnaud L., et al. (2024). Heterotypic interaction promotes asymmetric division of human hematopoietic progenitors. Development. 151:dev203088.
4. Loeffler D., et al. (2024). Asymmetric cell division of hematopoietic stem cells: recent advances, emerging concepts, and future perspectives. Frontiers in Hematology. 1:1373554.
5. Shin J.Y., et al. (2014). Non-muscle myosin II controls human hematopoietic stem-progenitor cell fate choice in response to matrix mechanics. Cell Stem Cell. 15:725–737.
6. Florian M.C., et al. (2012). Cdc42 activity regulates hematopoietic stem cell aging and rejuvenation. Cell Stem Cell. 10:520–533.